Detalhe da pesquisa
1.
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Br J Cancer
; 126(3): 514-520, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480094
2.
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
BMC Cancer
; 22(1): 407, 2022 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421940
3.
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
Invest New Drugs
; 39(3): 812-820, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409898
4.
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Lancet Oncol
; 21(12): 1589-1601, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125909
5.
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Cancer
; 126(14): 3219-3228, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365229
6.
A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.
Invest New Drugs
; 37(4): 755-762, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172443
7.
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Lancet Oncol
; 19(1): 101-114, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169877
8.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979383
9.
CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates.
Eur Radiol
; 28(12): 5069-5075, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869174
10.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
11.
Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma.
Carcinogenesis
; 38(3): 271-280, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049629
12.
Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.
Clin Proteomics
; 13: 31, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799870
13.
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Invest New Drugs
; 34(3): 355-63, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996385
14.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704439
15.
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).
Cancer
; 120(15): 2343-51, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752945
16.
CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report.
JCO Precis Oncol
; 8: e2300677, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603654
17.
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300555, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513170
18.
A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.
Br J Haematol
; 180(3): 445-448, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650362
19.
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.
Invest New Drugs
; 31(6): 1587-91, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013936
20.
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer.
Hematol Oncol Clin North Am
; 37(3): 475-487, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024388